Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations
Author(s) -
Xiaoying Liu,
Kabir Mody,
Francine B. de Abreu,
J. Marc Pipas,
Jason D. Peterson,
Torrey L. Gallagher,
Arief A. Suriawinata,
Gregory H. Ripple,
Kathryn Cunningham Hourdequin,
Kerrington D. Smith,
Richard J. Barth,
Thomas A. Colacchio,
Michael J. Tsapakos,
Bassem I. Zaki,
Timothy B. Gardner,
Stuart R. Gordon,
Christopher I. Amos,
Wendy A. Wells,
Gregory J. Tsongalis
Publication year - 2014
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2014.225565
Subject(s) - gnas complex locus , kras , stk11 , cdkn2a , biology , cancer research , pseudomyxoma peritonei , ros1 , hras , pdgfra , adenocarcinoma , cancer , gene , mutation , genetics , appendix , paleontology , gist , stromal cell
Some epithelial neoplasms of the appendix, including low-grade appendiceal mucinous neoplasm and adenocarcinoma, can result in pseudomyxoma peritonei (PMP). Little is known about the mutational spectra of these tumor types and whether mutations may be of clinical significance with respect to therapeutic selection. In this study, we identified somatic mutations using the Ion Torrent AmpliSeq Cancer Hotspot Panel v2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom